SGMT vs UBER · rev $2.0M vs P/E 18, rev $52.02B
Sagimet Biosciences Inc. Series A Common Stock (SGMT) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
SGMT currently screens at market cap $403.2M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the SGMT and UBER stock pages for the full models.
Not investment advice.